Case C-118/24, Laboratoires Eurogenerics and Theramex France: Judgment of the Court (Second Chamber) of 23 April 2026 (request for a preliminary ruling from the Conseil d’État – France) – EG Labo Laboratoires Eurogenerics SAS, Theramex France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM), Biogaran SAS (Reference for a preliminary ruling – Directive 2001/83/EC – Medicinal products for human use – Articles 28 and 29 – Decentralised procedure for marketing authori
62024CA0118 · CA · 2026-04-23 · sector 6